Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2003
10/23/2003WO2003087080A1 Medicinal composition for improving angiotension-regulating function of blood vessel endothelium
10/23/2003WO2003087074A1 Phenol compound, process for producing the same, and intermediate therefor
10/23/2003WO2003087062A2 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
10/23/2003WO2003087061A1 Pyrazole compounds as anti-inflammatory and analgesic agents
10/23/2003WO2003087050A2 Novel perindopril salt and pharmaceutical compositions containing same
10/23/2003WO2003087042A1 Occlusive composition comprising a poly (2-cyanoacrylate) monomer
10/23/2003WO2003087040A2 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
10/23/2003WO2003087037A1 Substituted aryl amides
10/23/2003WO2003086503A2 Electrocardiographic aspects of chf treatment
10/23/2003WO2003086468A1 Aqueous dispersible steryl ester compositions
10/23/2003WO2003086458A1 Recombinant anti-interleukin-9 antibodies
10/23/2003WO2003086448A1 Use of c5a receptor antagonist in the treatment of fibrosis
10/23/2003WO2003086440A1 Novel use of the extract of processed ginseng and saponin isolated therefrom
10/23/2003WO2003086437A1 Composition for preventing arteriosclerosis
10/23/2003WO2003086423A1 Low-dose potassium supplementation for the prevention and treatment of hypertension
10/23/2003WO2003086411A1 Compounds and preparation methods of carboxylate and monoester succinate derivative of diosgenin
10/23/2003WO2003086405A1 Solid dispersion composition
10/23/2003WO2003086401A1 Use of ranolazine for the preparation of a medicament for the treatment of arrhythmias
10/23/2003WO2003086400A1 N-substituted pyridinone and pyrimidinone derivatives for use as lp-pla2 inhibitors in the treatment of artherosclerosis
10/23/2003WO2003086394A1 Inhibitors of akt activity
10/23/2003WO2003086390A1 Imidazole compounds as anti-inflammatory and analgesic agents
10/23/2003WO2003086386A1 Therapeutic methods and compositions involving isoflav-3-ene and isoflavan structures
10/23/2003WO2003086382A1 Tnp-470 polymer conjugates and use thereof
10/23/2003WO2003086376A1 Patch and process for producing the same
10/23/2003WO2003086373A1 Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds
10/23/2003WO2003086371A2 Use of ep4 receptor ligands in the treatment of il-6 involved diseases
10/23/2003WO2003086351A1 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
10/23/2003WO2003086326A2 G-type peptides to ameliorate atherosclerosis
10/23/2003WO2003086325A2 Cyanamides useful as reversible inhibitors of cysteine proteases
10/23/2003WO2003086324A2 Preparation and use of a stable formulation of allosteric effector compounds
10/23/2003WO2003086317A2 Protein a compositions and methods of use
10/23/2003WO2003086315A2 Tyrosine kinase inhibitors
10/23/2003WO2003086314A2 Tyrosine kinase inhibitors
10/23/2003WO2003086309A2 NF-κB INHIBITORS
10/23/2003WO2003086306A2 5ht2c receptor modulators
10/23/2003WO2003086288A2 Bicyclic amides
10/23/2003WO2003086282A2 Nitric oxide donors, compositions and methods of use
10/23/2003WO2003086078A1 Method of reducing calcified arterial plaque buildup and cellular malfunction and for balancing ionic calcium
10/23/2003WO2003057252A8 Human mast cell-expressed membrane proteins
10/23/2003WO2003057147A3 Useful aroyl pyrrole heteroaryl methanones and methanols
10/23/2003WO2003055848A3 Urea derivatives as vr1- antagonists
10/23/2003WO2003045523A3 Therapeutic coating for an intravascular implant
10/23/2003WO2003039473A3 Method for treating or preventing inflammatory diseases
10/23/2003WO2003032902A3 Tumor targeted photodiagnostic-phototherapeutic agents
10/23/2003WO2003031466A3 Angiotensin peptide-carrier conjugates and uses thereof
10/23/2003WO2003029410A3 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER
10/23/2003WO2003027094A3 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
10/23/2003WO2003016248A3 Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace)
10/23/2003WO2003014307A3 Antisense modulation of apolipoprotein(a) expression
10/23/2003WO2003008576A3 Synthetic double stranded oligonucleotides for targeted inhibition of gene expression
10/23/2003WO2003007954A3 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
10/23/2003WO2003007872A3 Process for the preparation of citalopram hydrobromide
10/23/2003WO2002079456A3 A method for the preparation of immunologically inert amniotic membranes
10/23/2003WO2002077216A3 Ikk2 variant, dino gene, lectin-like receptor gene, and proteins encoded thereby
10/23/2003WO2002067688A8 Noninvasive measurements of chemical substances
10/23/2003WO2002066494A8 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
10/23/2003WO2002061998A9 Access parameter adaptation and packet data resource management using detailed mobile status information
10/23/2003WO2002046384A3 Kinases and phosphatases sequences, and use thereof
10/23/2003WO2002042272A8 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
10/23/2003WO2002036630A3 Renin and/or proprenin receptor protein, nucleic acid coding for same and uses thereof
10/23/2003WO2001047562A8 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
10/23/2003WO2001045641A8 Inhibitors of thrombin induced platelet aggregation
10/23/2003WO2001041754A8 Inhibitors of collagen-induced platelet aggregation
10/23/2003WO2001002567A8 16405 receptor, a g-protein coupled receptor
10/23/2003WO2001000812A8 22012, a novel human carboxypeptidase
10/23/2003US20030199701 Treating under hydrolyzing conditions a hydantoin compound to form an alpha-amino acid derivative
10/23/2003US20030199698 Anticoagulants such as 2'-tert-butylaminosulfonylbiphenyl-4-yl-(3-(5-methyl-1,2,4-oxadiazol-3 -yl)benzyl)(2-cyanoethyl) carbamate, used for prophylaxis of cardiovascular disorders
10/23/2003US20030199689 Heterocyclic nitrogen compounds such as 1-(5-(5-Chlorothiophen -2-yl)-isoxazol-3-ylmethyl)-1H-indole-2-carboxylic acid (1-isopropyl-piperidin-4-yl)-amide, used as anticoagulants for prophylaxis of cardiovascular disorders
10/23/2003US20030199571 Useful in treatment and prophylaxis of conditions mediated by s-CD23 or tumor necrosis factor; autoimmune disease, inflammation, allergy
10/23/2003US20030199569 Pyrrolidine derivatives
10/23/2003US20030199568 Salt of perindopril and pharmaceutical compositions containing it
10/23/2003US20030199563 Heterocyclic containing biphenyl aP2 inhibitors and method
10/23/2003US20030199562 Substituted benzoxazoles as estrogenic agents
10/23/2003US20030199559 Process for making amlodipine maleate
10/23/2003US20030199553 Antidiabetic agents
10/23/2003US20030199552 Amide derivatives as NMDA receptor antagonists
10/23/2003US20030199550 Cyclohexane derivatives containing amine or amine oxide, useful for treating hypercholesterolemia and hyperlipemia
10/23/2003US20030199549 Novel piperidine based MCH antagonists for treatment of obesity and CNS disorders
10/23/2003US20030199548 Administering quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives containing one of the ring selected from benzene, pyridine, thienyl, furanyl, imidazolyl and triazolyl for therapy in pain management
10/23/2003US20030199541 topical bactericides and disinfectants for surgical instruments; staphylococci; coliform bacteria; 7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide; bridged bicyclic ureas or carbamates having bridgehead nitrogen; (SML pat indexing merged to app)
10/23/2003US20030199534 Kinase inhibitors
10/23/2003US20030199530 New compounds derived from quinazoline
10/23/2003US20030199526 Pyrimidine-based compounds useful as GSK-3 inhibitors
10/23/2003US20030199525 Kinase inhibitors
10/23/2003US20030199513 Cinnoline derivatives and use as medicine
10/23/2003US20030199510 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
10/23/2003US20030199505 Anticoagulants as inhibitors of factor Xa; treating thrombosis, or aftertreatment following angioplasty and coronary bypass operations
10/23/2003US20030199504 Anticoagulants as inhibitors of factor Xa; treating thrombosis, or aftertreatment following angioplasty and coronary bypass operations
10/23/2003US20030199502 Indoloquinazolinones
10/23/2003US20030199501 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia
10/23/2003US20030199498 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
10/23/2003US20030199497 Novel calcium receptor active molecules and method for preparing same
10/23/2003US20030199493 A dibenzofuranazepine derivatives for use as therapeutic treatment of Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis, amyotrophic lateral sclerosis, epilepsy, stroke, cerebral trauma
10/23/2003US20030199492 Combination therapy
10/23/2003US20030199491 Quinoline derivatives having vegf inhibiting activity
10/23/2003US20030199483 Aldosterone receptor antagonist and alpha-adrenergic modulating agent combination therapy for prevention or treatment of pathogenic conditions
10/23/2003US20030199482 Anticholesterol agents; a drug mixture for treating hypercholesterolemia comprising an apical sodium co-dependent bile acid transport inhibitor, enzyme inhibitors of a cyclooxygenase-2
10/23/2003US20030199479 Oxa(thia)zolidine derivative and anti-inflammatory drug
10/23/2003US20030199478 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation
10/23/2003US20030199464 Regeneration of endogenous myocardial tissue by induction of neovascularization
1 ... 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 ... 1595